Synthesis, bioactivity, and cloning of the L-type calcium channel blocker omega-conotoxin TxVII

T Sasaki1, Z P Feng, R Scott

  • 1Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida-shi, Tokyo 194-8511, Japan.

Biochemistry
|October 3, 1999
PubMed

Insights

Omega-conotoxin TxVII, a novel L-type calcium channel blocker, was synthesized and structurally characterized. This conotoxin exhibits unique properties and specific targeting, highlighting the versatility of conotoxin scaffolds.

Area of Science:

  • * Neuroscience and Pharmacology
  • * Peptide Chemistry and Structural Biology

Background:

  • * Omega-conotoxins are known calcium channel blockers, but TxVII is the first reported to target L-type currents.
  • * TxVII possesses a unique sequence with a net negative charge and high hydrophobicity, differing from other omega-conotoxins while retaining the conserved cysteine framework.

Purpose of the Study:

  • * To synthesize omega-conotoxin TxVII and determine its disulfide bond pairings for structural insights.
  • * To investigate the biological function of TxVII, including its effects on voltage-dependent calcium currents and synaptic transmission.
  • * To explore the specificity of TxVII's interaction with L-type calcium channels.

Main Methods:

  • * Chemical synthesis of TxVII and optimization of air oxidation conditions for proper folding.
  • * Determination of disulfide bond pairings using enzymatic fragmentation and chemical synthesis.
  • * Assessment of TxVII's biological activity on cultured Lymnaea RPeD1 neurons and PC12 cells.

Main Results:

  • * Optimized folding conditions using a cationic buffer and hydrophobic solvent facilitated TxVII synthesis.
  • * Synthetic TxVII suppressed slowly inactivating voltage-dependent calcium currents and synaptic transmission in Lymnaea neurons.
  • * TxVII did not block L-type calcium channels in PC12 cells, indicating potential phyletic or subtype specificity.
  • * Disulfide bond analysis revealed TxVII shares the same pattern as other omega-conotoxins, and its CD spectrum is similar to MVIIA and MVIIC.

Conclusions:

  • * TxVII is a structurally conserved omega-conotoxin that specifically blocks L-type calcium currents and synaptic transmission.
  • * The study highlights the evolutionary versatility of the conotoxin scaffold, enabling the targeting of different ion channels.
  • * TxVII's unique properties and specificity offer potential for further research in neuropharmacology.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...